Calithera Biosciences Inc
NASDAQ:CALA

Watchlist Manager
Calithera Biosciences Inc Logo
Calithera Biosciences Inc
NASDAQ:CALA
Watchlist
Price: 0.02 USD
Updated: May 20, 2024

Calithera Biosciences Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Calithera Biosciences Inc
Additional Paid In Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Calithera Biosciences Inc
NASDAQ:CALA
Additional Paid In Capital
$510.7m
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Additional Paid In Capital
$20.7B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Additional Paid In Capital
$6.8B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
2%
Amgen Inc
NASDAQ:AMGN
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Additional Paid In Capital
$7.3B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Additional Paid In Capital
$11.9B
CAGR 3-Years
20%
CAGR 5-Years
23%
CAGR 10-Years
18%

See Also

What is Calithera Biosciences Inc's Additional Paid In Capital?
Additional Paid In Capital
510.7m USD

Based on the financial report for Dec 31, 2022, Calithera Biosciences Inc's Additional Paid In Capital amounts to 510.7m USD.

What is Calithera Biosciences Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
11%

Over the last year, the Additional Paid In Capital growth was 2%. The average annual Additional Paid In Capital growth rates for Calithera Biosciences Inc have been 6% over the past three years , 11% over the past five years .